VIRI - Virios Therapeutics GAAP EPS of -$0.54 beats by $0.29 March, 17 2022 07:14 AM Virios Therapeutics Inc. Virios Therapeutics press release (NASDAQ:VIRI): Q4 GAAP EPS of -$0.54 beats by $0.29. Cash on hand of $14.0 million on December 31, 2021 For further details see: Virios Therapeutics GAAP EPS of -$0.54 beats by $0.29